Código QR (código de barras bidimensional)

Use of programmed cell death protein 1 (PD-1) inhibitor therapy in HIV-infected patients with advanced cancer: a single-center study from China

Abstract Background Anti-PD-1 antibodies have been approved for treating several cancer. However, data regarding the safety and efficacy of these agents in HIV-infected patients with cancer is lacking, because these patients are frequently omitted from clinical trials. Objectives The primary aim of...

ver descrição completa

Na minha lista:
Principais autores: Luling Wu, Jie Su, Junyang Yang, Ling Gu, Renfang Zhang, Li Liu, Hongzhou Lu, Jun Chen
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2023-05-01
coleção:Infectious Agents and Cancer
Assuntos:
HIV
Cancer
PD-1
ICIs
Safety and outcomes
Acesso em linha:https://doi.org/10.1186/s13027-023-00512-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados